Cite
HARVARD Citation
Israeli, E. et al. (n.d.). Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial. Clinical and experimental immunology. pp. 362-372. [Online].